This article is part of a series sponsored by HLTH highlighting topics that will be discussed at the HLTH conference November 13-16 in Las Vegas.
The wrappings are off the preliminary agenda for the HLTH 2022 conference, scheduled for November 13-16 at the Venetian Expo in Las Vegas. It’s peppered with a wide variety of topics and speakers occupying niches across the healthcare ecosystem. A new open plan format will help attendees balance checking out topics they’re keen to see at the conference with networking and meetings. Here’s a preview of some of what the conference has to offer, based on the agenda descriptions.
Healthcare no buzzwords edition, Disco Stage, Sunday, Nov. 13, 3:30-4:10 pm
Let’s agree to not use the buzzwords here and talk specifically about health data use cases. If cash is king, then data is its queen. The sheer quantity of health-related apps built on top of data from a variety of clinical and non-clinical sources is astounding. Patients now have the ability to monetize their own health data through DAOs and other blockchain-based platforms.
- Andrea Fletcher, executive director, Digital Service at the Centers for Medicare and Medicaid Services (moderator)
- Aashima Gupta, Global Director, Healthcare Solutions, Google
- Dr. Arif Nathoo, CEO, Komodo Health
- Najat Khan, Chief Data Science Officer, Janssen Research & Development
- Troy Bannister, CEO, Particle Health
The ununited mental state of America, Arena stage, Monday, Nov. 14, 10:00-10:50 am
A panel on mental health, the speakers will share their perspectives on where the focus of their efforts should be to help people in desperate need of care.
- Nikhil Krishnan, founder, Out-Of-Pocket Health (moderator)
- Dr. David Stark, chief medical officer, Morgan Stanleywith varying
- Dr. Varun Choudhary, chief medical officer, Talkspace
- Dr. Yusra Benhalim, senior national medical director, Optum
Women are healthcare, Gallery stage, Monday, Nov. 14, 11:50-12:20 pm
Women juggle multiple roles as caregivers, mothers, healthcare professionals and teachers. It’s been a watershed year for women’s health, from the U.S. Supreme Court’s overturning of Roe v. Wade, states invoking their own abortion bans with varying degrees of severity and the ripple effect of this legislation. Shortages impacting tampons to baby formula and the maternal mortality rate continues to climb. From incumbents to startups, there are many organizations with trailblazing missions seeking to change this narrative for future generations. Join five women leaders as they candidly discuss this pivotal time in women’s health.
- Dr. Christina Jenkins, venture partner, Phoenix Venture Partners (moderator)
- Alicia Jackson, CEO and founder, Evernow
- Christine Henningsgaard, co-founder and CEO, Quilted Health
- Dr. Margaret Larkins-Pettigrew, chief clinical officer, diversity equity and inclusion, Allegheny Health Network and Highmark Health
- Lori Evans Bernstein, co-founder and CEO, Caraway
Cleared for takeoff: Health pilots and partnerships, Gallery stage, Monday, Nov. 14, 3:30-4:10 pm
The challenges within the healthcare industry are too large to face alone. Health organizations are constantly on the hunt for new partners and solutions with which to collaborate. With the sheer number of pitches, pilots and deals, what is the best way to measure a partnership’s success? Across providers, payers and pharma, what metrics are being used to quantify effectiveness? What specifics are each looking for when bringing on a new collaboration partner? Gain new insights by attending this panel.
- Alisha Alaimo, president Biogen, U.S. Organization (moderator)
- Arpa Garay, chief commercial officer, Moderna
- Paul Markovich, president and CEO, Blue Shield of California
- Ralph de la Torre, chairman and CEO, Steward Health Care Systems
Doom or boom? Digital health’s financial future, Arena stage, Tuesday, Nov 15, 11:00-11:40 am
In a bullish market, it’s easier to take risks in the short term. The real test of resilience is in a market downturn, which is where we find ourselves now. Has the digital health bubble finally burst? This panel will take a step back and evaluate the current state of the market, explore short and long term predictions and dissect what founders should be doing during this unsettling time. Layoffs and down rounds are not always the answer.
- Chrissy Farr, health tech investor, OMERS Ventures (moderator)
- Cheri Mowrey, head of U.S. healthcare, investment banking, Morgan Stanley
- Jonathan Bush, founder and CEO, Zus Health
- Michael Yang, managing partner, OMERS Ventures
- Missy Krasner, venture chair, Redesign Health
Beyond the press release: Chief health equity officer impact, Gallery stage, Tuesday, Nov. 15, 11:00-11:40 am
Over the last few years, our Google alerts have been full of hiring announcements from top organizations appointing their first ever chief health equity officer (CHEO), marking an important turn in our industry’s prioritization of addressing health disparities. These leaders come with a plethora of experience and the passion to create a real impact. Now that the first wave of hires have had time to become acclimated to their roles and mission, this group of CHEOs will highlight their accomplishments to date and discuss their plans to advance health equity.
- Mary Stutts, chief global health equity and inclusion officer, Real Chemistry (moderator)
- Dr. Nwando Olayiwola, chief health equity officer and senior vice president, Humana
- Dr. Joneigh Khaldun, vice president and chief health equity officer, CVS Health
- Dr. Kulleni Gebreyes, U.S. consulting health care sector leader, Deloitte
- Leon Clark, chief research and health equity officer, Sutter Health
D2C as easy as B2B? Garden Stage, Monday, Nov. 14, 3:30-4:10pm
So you want to start a digital health company? First, you’ll need to identify your customers. You can dive right into the belly of the B2B beast and sell to physicians, employers, health plans, etc, but this will be an arduous journey. Health organizations are notoriously change averse and if you’re not already on their radar, it can be challenging to break in. On the flip side, you can try your hand in the consumer marketplace. People are hungrier than ever for solutions that can make a direct impact on their health and well-being. The D2C path comes with steep competition and consumer marketing ambiguity, but if you do it right, you may just become a household name. There is no wrong answer, but these leaders have been through it all and come with the stories to tell.
- Aike Ho, partner, ACME Capital (moderator)
- Dr. Robin Berzin, MD, CEO and founder, Parsley Health
- Russell Glass, CEO, Headspace Health
- Sarah Jones Simmer, CEO, Found
- Sid Viswanathan, co-founder and CEO, Truepill
The broken trust between public and health, Arena Stage, Tuesday, Nov. 15, 10:10-10:50am
Let’s face it, the trust has been lost between American citizens and our government institutions. Has the wound gotten too deep to mend? Our federal agencies are expected to rise above the fragmentation within our health industry and coordinate a cohesive national response to health emergencies. When this doesn’t happen, the finger pointing comes out, but like in any healthy relationship, communication is key. Three foremost experts will share their idea of achieving harmony between the public and public health officials. Happy health, happy life!
- Anjalee Khemlani, reporter, Yahoo! Finance (moderator)
- Dr. Amy Abernethy, president of clinical research platforms and former principal deputy commissioner at U.S. FDA, Verily
- Dr. Leana Wen, public health professor, George Washington University
- Ezekiel J. Emanuel, MD, PhD, vice provost global initiatives, University of Pennsylvania
What’s plaguing our health? Gallery stage, Tuesday, Nov. 15, 3:30-4:10 pm
Our generation’s mark on health’s history is still to be determined. Will we be defined by the escalating mental health crisis, prevalence of chronic conditions, childhood obesity, the Covid-19 pandemic, women’s health, or all of the above? Unlike the global pandemic, we have foresight into these ballooning crises, giving us a head start to create a plan to curb them now and change the trajectory of health’s future. Join four health luminaries to discuss what keeps them up at night and their opinions on where the biggest solutions lie within the sea of health innovation.
- Greg Meyers, executive vice president, chief digital and technology officer, Bristol Myers Squibb (moderator)
- Javier Rodriguez, CEO, DaVita
- Paul King, president and CEO, Stanford Medicine Children’s Health
- Dr. Vivian Lee, president, Verily health platforms, Verily
WELL by HLTH Bonus session: Is sleep a universal remedy? Garden Stage, Monday, Nov. 14, 12:30-12:50pm
Sleep affects virtually every tissue in our bodies, growth and stress hormones, the immune system, appetite, breathing, blood pressure, and cardiovascular health. Despite its massive importance to our overall health, the U.S. is facing an epidemic of sleeplessness. It’s only recently that we’ve begun to scratch the surface of how lack of sleep is hurting us. Hear how biometric data can help people make personal lifestyle choices that can benefit sleep outcomes, why employers are looking at sleep and recovery as an unlock for their employees to promote wellbeing and performance and what led the American Heart Association to update its guidelines this year to include sleep in its cardiovascular checklist.
- Nancy Brown, general partner, Oak HC/FT (moderator)
- Tom Hale, CEO, ŌURA
Clinical trials and tribulations, Arena Stage, Wednesday, Nov. 16, 10:10-10:50am
The clinical trial process needs a refresh. The antiquated system is ripe for innovation, but it’s not been an easy road to change. Diversity in clinical research and trials is still a persistent issue. We are not representative of all patients, leading to a massive problem down the road when the treatment is ultimately approved and yet not efficacious in all who can benefit. Decentralizing the process is making inroads, but more progress is needed to have a system free of disparities. What have we been doing wrong this whole time? Experts from all parts of the health industry will lead the way to a better system, so let’s hear them out.
- Vineeta Agarwala, MD PhD, general partner, Andreessen Horowitz (moderator)
- Christopher P. Boone, vice president, global head of health economics & outcomes research, AbbVie
- Ed Ramos, PhD, principal science officer & co-founder digital trials center, CareEvolution & Scripps Research
- Ramita Tandon, chief clinical trials officer, Walgreens
- Sheenu J. Kachru, CEO, Optum life sciences, Optum
Photo: Getty Images
